Zymetech
Reykjavík
About Zymetech
Zymetech is a globally leading company in research, development, production and sales of marine-derived enzymes for therapeutic application. The company's technology of developing and manufacturing formulations containing marine-derived enzymes is called the Penzyme® technology and is at the core of its intellectual property. Zymetech's use of cod enzymes (called Penzyme®) for therapeutic application is patented-protected in 27 countries. Core and clinical research has demonstrated effectiveness of Penzyme® against a variety of skin conditions, wound healing and viral and bacterial infections.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $873.9K
- Funding stage: M&A
- Last round: Grant (May 2015)
- Website: zymetech.com
- Phone: (354)551-7312
Industries & Categories
Biotechnology, Clinical Trials, Health Care, Manufacturing, Therapeutics
Canonical: https://fsome.com/organization/zymetech-2705712 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.